Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
  • Massachusetts
  • USA
Investment stages
  • Seed
Industries
  • Pharma
  • Diagnostics
  • Biotechnology
  • Enterprise Software
  • Generative AI
  • Digital Health
  • Health Tech
  • Deep Tech
About
Atria Ventures invests in early-stage life sciences startups at the nexus of technology and biology, offering venture capital and private equity support.
Min check size
$250K
Max check size
$1M
Fund size
NPS

Investment Thesis

Atria Ventures invests in techbio + health at early stage.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Specializes in investing in early-stage technology companies across North America and Europe. With deep experience in fintech and SaaS sectors, the manager has completed over 50 deals, achieving numerous successful exits. Known for a hands-on approach and a focus on growth potential, the strategy emphasizes long-term value creation. Recognized for a strong track record in identifying emerging trends and fostering innovation.
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp